Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.44 |
| ▸ | BDKRB2 | P30411 | 4/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8391366 | 0.92 | DNM1 (0.52) | DNM1BDKRB2 | |
| SCHEMBL8390161 | 0.92 | DNM1 (0.52) | DNM1BDKRB2 | |
| SCHEMBL608094 | 0.86 | POLB (0.39) | CNR2POLBKDM4EALDH1A1OPRM1 | |
| SCHEMBL31576098 | 0.85 | KIF11 (0.42) | DNM1SIGMAR1 | |
| SCHEMBL8391368 | 0.85 | DNM1 (0.43) | DNM1BDKRB2 | |
| SCHEMBL8566280 | 0.84 | DNM1 (0.41) | DNM1BDKRB2CNR2POLBSIGMAR1 | |
| SCHEMBL4384493 | 0.82 | DNM1 (0.40) | DNM1BDKRB2CNR2POLBSIGMAR1 | |
| Butyltriphenylphosphonium SCHEMBL4389652 | 0.82 | HIF1A (0.50) | CNR2POLBALDH1A1TSHR | |
| Octane SCHEMBL18395350 | 0.82 | DNM1 (0.44) | DNM1SIGMAR1TSHRLTA4H | |
| SCHEMBL20566136 | 0.82 | DNM1 (0.43) | DNM1BDKRB2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164875-A | Preparation method of tubular metal copper phthalocyanine polymer and cyclic carbonate | 浙江理工大学 | 2023-12-05 | — | — | CN | claimed |
| US-20220127238-A1 | PROCESS FOR THE PREPARATION OF ANGIOTENSIN II RECEPTOR BLOCKERS | HETERO LABS LIMITED (IN) | 2022-04-28 | — | — | US | claimed |
| US-11236227-B2 | Heat dissipation material adhering composition, heat dissipation material having adhesive, inlay substrate, and method for manufacturing same | TATSUTA ELECTRIC WIRE & CABLE CO., LTD. (JP) | 2022-02-01 | — | — | US | claimed |
| US-7709168-B2 | Phosphonium containing charge transport layer photoconductors | XEROX CORPORATION (US) | 2010-05-04 | — | — | US | claimed |
| US-20090092915-A1 | PHOSPHONIUM CONTAINING CHARGE TRANSPORT LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | claimed |
| US-20090092914-A1 | PHOSPHONIUM CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | claimed |
| EP-0378858-B1 | Process for the preparation of branched thermoplastic polycarbonates | GEN ELECTRIC (US) | 1996-06-12 | — | — | EP | claimed |
| EP-0349874-B1 | A new and improved method for the preparation of cross-linked polycarbonates, and compositions made therefrom | GEN ELECTRIC (US) | 1994-08-31 | — | — | EP | claimed |
| US-5124407-A | Crosslinkable compositions comprising cyclic polycarbonates and glycidyl group-containing copolymers | GENERAL ELECTRIC COMPANY (US) | 1992-06-23 | — | — | US | claimed |
| US-5115024-A | Heating a cyclic polycarbonate oligomer and a glycidyl acrylate copolymer in the presence of a polycarbonate formation catalyst | GENERAL ELECTRIC COMPANY (US) | 1992-05-19 | — | — | US | claimed |
| US-5097008-A | Tetraphenylborate catalyst, melt strength | GENERAL ELECTRIC COMPANY (US) | 1992-03-17 | — | — | US | claimed |
| US-5021521-A | Process of reacting branched thermoplastic polycarbonate with polyhydric phenol having more than two hydroxy groups | GENERAL ELECTRIC COMPANY (US) | 1991-06-04 | — | — | US | claimed |
| US-4965657-A | BROMINATED EPOXY RESIN, ANTIMONY OXIDE, AND QUATERNARY PHOSPHONIUM TETRASUBSTITUTED BORATE | HITACHI LTD. (JP) | 1990-10-23 | — | — | US | claimed |
| EP-0378858-A2 | Process for the preparation of branched thermoplastic polycarbonates | GENERAL ELECTRIC COMPANY (US) | 1990-07-25 | — | — | EP | claimed |
| EP-0349874-A2 | A new and improved method for the preparation of cross-linked polycarbonates, and compositions made therefrom | GENERAL ELECTRIC COMPANY (US) | 1990-01-10 | — | — | EP | claimed |
| US-4888400-A | OPTICAL CLARITY, TOUGHNESS, DIMENSIONAL STABILITY, IMPACT STRENGTH | GENERAL ELECTRIC COMPANY (US) | 1989-12-19 | — | — | US | claimed |
| US-3947395-A | Epoxy surface coating compositions | HITACHI, LTD. (JA) | 1976-03-30 | — | — | US | claimed |
| JP-2169674-A | — | — | None | — | — | JP | disclosed |
| EP-0198338-A2 | Method for preparing linear polycarbonates from cyclic oligomers | GENERAL ELECTRIC COMPANY (US) | 1986-10-22 | — | — | EP | disclosed |
| US-4605731-A | DISCOLORATION INHIBITION; HEATING AT LOW TEMPERATURE | GENERAL ELECTRIC COMPANY (US) | 1986-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127238-A1 | PROCESS FOR THE PREPARATION OF ANGIOTENSIN II RECEPTOR BLOCKERS | AGTR2, AGTR1, ADRB1 | DNM1 2968/4885BDKRB2 36/4885CNR2 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.